In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Soleno Therapeutics, Inc. is one of them. Soleno Therapeutics, Inc. (NASDAQ:SLNO) tops our list for being one of the most oversold stocks. It is a clinical-stage biotech focused on rare diseases and has seen significant stock volatility in 2025 following the commercial launch of its lead product, VYKAT XR, the first FDA-approved treatment for hyperphagia in Prader-Willi Syndrome (PWS). The therapy addresses ...

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Thursday.Following the market opening Thursday, the Dow traded down 0.04% to 46,000.59 while the NASDAQ rose 0.49% to 22,370.12. The S&P 500 also rose, gaining, 0.29% to 6,619.34.Check This Out: This Target Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For ThursdayLeading and Lagging SectorsInformation technology shares jumped by 0.8% on Thursday.In trading on Thursday, materials ...

Search fieldEntering text into the input field will update the search result belowEntering text into the input field will update the search result below ...

公司活动安排 - 公司将于2025年9月24日太平洋时间上午9:55通过网络直播展示其研发进展 [1] - 管理层将在会议期间与合格投资者进行一对一交流 [2] - 演示实况可通过公司官网投资者专区活动页面观看 [2] 公司业务与技术平台 - 公司为临床阶段生物技术企业 专注于开发新一代细胞与基因疗法 [2] - 核心技术为基因回路平台 可增强治疗精确度与控制性 [2] - 基因回路设计具备四大功能：精准杀伤癌细胞 保护健康细胞 提高靶组织特异性 以及给药后可控性 [2] 研发管线与合作 - 全资管线包含针对血液瘤和实体瘤的细胞疗法 [2] - 临床前数据证实基因回路在NK细胞和T细胞中均有效 [2] - 正通过合作伙伴关系拓展基因回路在非肿瘤领域及其他治疗模式的应用潜力 [2] 信息披露渠道 - 公司通过官方网站及社交媒体平台（X和LinkedIn）发布重大信息 [3] - 披露内容涵盖公司公告 投资者演示材料 SEC文件 新闻稿及会议记录等 [3] - 投资者可通过www.sentibio.com获取最新企业动态 [3]

CRISPR Therapeutics (NASDAQ:CRSP) traded higher in the premarket on Thursday after J.P. Morgan initiated its coverage with an Overweight recommendation, noting how the company stands out in the gene editing space thanks to its pipeline potential. The Swiss biotech, which markets ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equities strongly rebounded in the second quarter. The S&P 500 Index returned 10.9%, and the benchmark Russell 3000 Index advanced 11.0%, as risk-on sentiment took hold following the pause in tariff implementation. The strategy outperformed the benchmark in the quarter, driven by the strength in portfolio construction acr ...

CAMBRIDGE, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that it will host a virtual Research Day on Wednesday, October 29, 2025 at 10:00 a.m. ET. In addition, members of Wave’s management team are scheduled to participate in several upcoming investor conferences. Details are as follows: Bernstein 2nd Annual Healthcare ForumDate: Wedne ...

SANTA ANA, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced that Paul Y. Song, M.D., Chairman and Chief Executive Officer of NKGen, will present at the 3rd China Great Bay Cell and Gene Therapy Forum, taking place in Guangzhou, China, September 25-26, 2025. Dr. Song will d ...

盘前交易概况 - 美东时间周四上午7:25盘前交易出现显著活动 多个股票出现早期价格波动 预示开盘前存在潜在机会 [1] - 盘前交易为活跃交易者提供识别潜在突破、反转或剧烈价格波动的先发优势 早期动向通常预示常规交易时段的动量延续 [1] 盘前涨幅领先股票 - 89bio Inc(ETNB)大涨83%至14.84美元 位列涨幅榜首 [3] - Aptevo Therapeutics Inc(APVO)飙升75%至2.47美元 涨幅第二 [3] - Psyence Biomedical Ltd(PBM)上涨29%至4.82美元 Beam Global(BEEM)上升27%至3.23美元 [3] - 生物科技板块表现突出 前十涨幅股中医药类公司占六席 包括Akero Therapeutics(AKRO)涨12%至47.50美元 [3] - 新能源板块Beam Global涨27% FuelCell Energy(FCEL)涨9%至8.34美元 [3] - 人工智能相关企业MicroAlgo Inc(MLGO)涨14%至13.06美元 Roboai Inc(AIIO)涨6%至2.05美元 [3] 盘前跌幅显著股票 - Presidio Property Trust Inc(SQFT)重挫14%至7.58美元 领跌市场 [4] - Aeluma Inc(ALMU)和FGI Industries Ltd(FGI)均下跌10% 分别报15.18美元和7.65美元 [4] - Lazydays Holdings Inc(GORV)下跌9%至2.26美元 StableX Technologies(SBLX)跌8%至5.40美元 [4] - 餐饮零售业Cracker Barrel Old Country Store(CBRL)下跌7%至45.75美元 [4] - 生物制药公司Artelo Biosciences(ARTL)跌8%至4.48美元 SciSparc Ltd(SPRC)跌8%至4.10美元 [4]